Moreover, the role of oncogenic c-Myc (transcription factor) has been investigated in many cancers, and in particular, oncogenic expression of c-Myc is activated by aberrant upstream signaling, super-enhancer activation, chromosomal amplification, and translocation, resulting in cell proliferation and chemoresistance. Here, MYC is linked to cancer.